| COOPER COMPANIES |
| USA |
| Gesundheit |
| US2166485019 / A402VX |
| CP60 (Frankfurt) / COO (NASDAQ) |
| FRA:CP60, ETR:CP60, CP60:GR, NASDAQ:COO |
| - |
| https://www.coopercos.com.. |
|
The Cooper Companies Inc. is a global healthcare company that specializes in the production of medical devices, prominently focusing on contact lenses and women's health products. As a key player in t..
>Volltext.. |
| 13879.53 Mio. EUR |
| 16192.84 Mio. EUR |
| 3464.07 Mio. EUR |
| 897.48 Mio. EUR |
| 317.33 Mio. EUR |
| 1.59 EUR |
| 2356.16 Mio. EUR |
| 93.62 Mio. EUR |
| 673.85 Mio. EUR |
| 0.1 |
| -0.9% |
| -9.86% |
| - |
| - |
| - |
| 26.07.23 - 0.00160875€ 20.01.23 - 0.00160875€ >weitere anzeigen... |
| - |
| COOPER COMPANIES, COOPERCOMPANIES, COOPER COS |
| 02.03.26 |
|
||||
|
||||
|
||||
|